Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Dec. 24, 2017
Dec. 25, 2016
Operating Activities:    
Net (loss) income $ (5,953) $ 681
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization expense 363 329
Indefinite and long-lived asset impairment charges 0 32
Income tax provision in excess of (less than) income tax payments (Note 3) 5,697 (113)
Non-cash portion of share-based compensation expense 248 239
Net realized gains on marketable securities and other investments (23) (147)
Impairment losses on marketable securities and other investments 9 143
Other items, net 57 (4)
Changes in assets and liabilities:    
Accounts receivable, net 581 131
Inventories 162 (354)
Other assets (56) (16)
Trade accounts payable (248) (208)
Payroll, benefits and other liabilities 1,000 957
Unearned revenues (75) (84)
Net cash provided by operating activities 1,762 1,586
Investing Activities:    
Capital expenditures (226) (129)
Purchases of available-for-sale marketable securities (5,627) (4,117)
Proceeds from sales and maturities of available-for-sale securities 2,704 6,891
Deposits of investments designated as collateral 0 (1,950)
Acquisitions and other investments, net of cash acquired (122) (57)
Other items, net 10 43
Net cash (used) provided by investing activities (3,261) 681
Financing Activities:    
Proceeds from short-term debt 2,116 2,727
Repayment of short-term debt (1,149) (2,727)
Proceeds from issuance of common stock 134 131
Repurchases and retirements of common stock (225) (444)
Dividends paid (844) (784)
Payments of tax withholdings related to vesting of share-based awards (192) (172)
Other items, net (5) (42)
Net cash used by financing activities (165) (1,311)
Effect of exchange rate changes on cash and cash equivalents (3) (17)
Net (decrease) increase in cash and cash equivalents (1,667) 939
Cash and cash equivalents at beginning of period 35,029 5,946
Cash and cash equivalents at end of period $ 33,362 $ 6,885